RNAi Startup SanoGene Moves Brain Cancer Drug into IND-Enabling Studies

SanoGene core technology is an expressed RNAi approach developed in the lab of cancer researcher Jasti Rao at the University of Illinois College of Medicine at Peoria. Rao, however, is not affiliated with the company.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.